In addition, there were significant differences in the male sex ratio, body mass index, and HDL-C levels, prevalence of current smokers, and prevalence of angiotensin-converting enzyme inhibitors/angiotensin II receptor blocker use, but not in the triglyceride, LDL-C, HbA1c, EPA, DHA, and AA levels, DHA/AA ratio, prevalence of dyslipidemia, hypertension, and diabetes mellitus, and the other administered drugs. This evidence concerns the gene ACE and metabolic syndrome.